Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

19 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198 - Dosing Details

- 15/4/19 - 1 formulario, 2 itemgroups, 8 items, 1 idioma
Itemgroups: Administrative data, Dosing Details
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the Dosing Details form. It has to be filled in for all sessions each for day 1.

Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198 - Concomitant Medication

- 9/4/19 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Administrative data, Concomitant Medication
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the concomitant medication form. It has to be filled in if the subject takes concomitant medication during the study trial. Please complete drug section for all drugs (including OTC)/ vaccines taken by mother within 3 months prior or during pregnancy.

GSK Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/188 - Study Medication and Compliance Record

- 6/11/17 - 1 formulario, 2 itemgroups, 20 items, 1 idioma
Itemgroups: Study Medication And Compliance Record, Dose Reductions due to Adverse Experiences
Study ID: 101468/188 Clinical Study ID: SKF-101468/188 Study Title:A Study of the Maintained Efficacy and Safety of Ropinirole Versus Placebo in the Long Term Treatment of Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Parkinson Disease Module: Study Medication and Compliance Record

26072_GSK Ropinirole in Patients Suffering from Restless Legs Syndrome study medication and compliance 101468/190 - GSK Ropinirole in Patients Suffering from Restless Legs Syndrome study medication and compliance 101468/190

- 12/10/17 - 1 formulario, 6 itemgroups, 21 items, 1 idioma
Itemgroups: General Information, Study Medication, Medication Labels, DOSE REDUCTIONS DUE TO ADVERSE EXPERIENCES, MEDICATION LABELS, Withdrawal
Study ID: 101468/190 Clinical Study ID: SKF-101468/190 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome This is the study medication and compliance form.

OP MS Kurz Sub MS University Hospital Muenster (UKM) Subform

- 24/11/16 - 1 formulario, 1 itemgroup, 14 items, 1 idioma
Itemgroup: General Information
Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: OP MS Kurz Sub.

MS MedD Medication Editor University Hospital Muenster (UKM)

- 22/9/16 - 1 formulario, 3 itemgroups, 11 items, 1 idioma
Itemgroups: Immunsuppression, Frequently Used Other Medication, Medication Text
Hospital Routine Documentation Form at the University Hospital Muenster. Original Form name: MS MedD Medikamenten Editor.

CARDIOLOGY ADMISSION ORDERS - Mount Sinai Hospital Medical Center - CARDIOLOGY ADMISSION ORDERS, PHYSICIAN’S ORDER SHEET

- 30/7/15 - 1 formulario, 17 itemgroups, 69 items, 1 idioma
Itemgroups: Admission Details, Medical History, Admission Orders, Medication Order, ACE Inhibitor, ANGIOTENSIN RECEPTOR BLOCKER, Hydralazine/Nitrates, Diuretics, ALDOSTERONE ANTAGONIST, DIGITALIS, ANTICOAGULANT, HMG-CoA REDUCTASE INHIBITOR, Further Intravenous MEDICATIONS, ORAL POTASSIUM REPLACEMENT,, ORAL MAGNESIUM REPLACEMENT, OTHER MEDICATIONS, DISCHARGE PLANNING & EDUCATION
ODM derived from: http://www.rwjf.org/en/library/research/2008/06/cardiology-admission-orders-physician-s-order-sheet.html Mount Sinai Hospital Medical Center California Avenue at 15th Street Chicago, IL 60608

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial